Nexalis Therapeutics Limited (ASX:NX1)
Australia · Delayed Price · Currency is AUD 0.0150
0.00 (0.00%)
Sep 25, 2026, 10:49 AM AEST
Nexalis Therapeutics Market Cap
Nexalis Therapeutics has a market cap or net worth of 3.8 million as of October 9, 2026. It is the 47,218th most valuable company in the world and the 1,599th biggest in Australia. Its market cap has decreased by 50.60% in one year.
Market Cap
3.80M
Enterprise Value
3.72M
Revenue
1.07M
Global Rank
Country Rank
#1,599 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since January 11, 2017, Nexalis Therapeutics's market cap has decreased from 29.98M to 3.80M, a decrease of -87.34%. That is a compound annual growth rate of -19.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.28M | -60.36% |
| Dec 29, 2025 | 5.74M | -23.11% |
| Dec 30, 2024 | 7.47M | 35.76% |
| Dec 18, 2023 | 5.50M | -51.02% |
| Dec 29, 2022 | 11.24M | -25.89% |
| Dec 30, 2021 | 15.16M | 46.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 14.53M |
| AdAlta | 11.24M |
| Invex Therapeutics | 8.27M |
| Bio-Gene Technology | 7.01M |
| Vectus Biosystems | 6.53M |
| Acrux | 6.49M |
| Zelira Therapeutics | 5.95M |
| Biotron | 5.57M |